[신간의 별자리x] 우리/미술, 그리고 ‘슬픔의 박물관’

Pedagosko i psiholosko testiranje i procjenjivanje spadaju među najvažnije doprinose znanosti o ponasanju nasem drustvu i pružaju temeljna i znacajna poboljsanja u odnosu na ranije postupke. Iako se ne može ustvrditi da su svi testovi dovoljno usavrseni niti da su sva testiranja razborita i korisna, postoji velika kolicina informacija koje ukazuju na ucinkovitost kvalitetnih instrumenata u onim situacijama u kojima je njihovo koristenje potkrijepljeno validacijskim podacima. Pravilna upotreba testova može dovesti do boljih odluka o pojedincima i programima nego sto bi to bio slucaj bez njihovog koristenja, a također i ukazati na put za siri i pravedniji pristup obrazovanju i zaposljavanju. Međutim, losa upotreba testova može dovesti do zamjetne stete nanesene ispitanicima i drugim sudionicima u procesu donosenja odluka na temelju testovnih podataka. Cilj Standarda je promoviranje kvalitetne i eticne upotrebe testova te uspostavljanje osnovice za ocjenu kvalitete postupaka testiranja. Svrha objavljivanja Standarda je uspostavljanje kriterija za evaluaciju testova, provedbe testiranja i posljedica upotrebe testova. Iako bi evaluacija prikladnosti testa ili njegove primjene trebala ovisiti prvenstveno o strucnim misljenjima, Standardi pružaju okvir koji osigurava obuhvacanje svih relevantnih pitanja. Bilo bi poželjno da svi autori, sponzori, nakladnici i korisnici profesionalnih testova usvoje Standarde te da poticu druge da ih također prihvate.

Standards for educational and psychological testing

https://www.medpagetoday.com/upload/2008/3/6/CRC.pdf

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

The physical principles underlying some current biomedical applications of magnetic nanoparticles are reviewed. Starting from well-known basic concepts, and drawing on examples from biology and biomedicine, the relevant physics of magnetic materials and their responses to applied magnetic fields are surveyed. The way these properties are controlled and used is illustrated with reference to (i) magnetic separation of labelled cells and other biological entities; (ii) therapeutic drug, gene and radionuclide delivery; (iii) radio frequency methods for the catabolism of tumours via hyperthermia; and (iv) contrast enhancement agents for magnetic resonance imaging applications. Future prospects are also discussed.

https://iopscience.iop.org/article/10.1088/0022-3727/36/13/201/pdf

Applications of magnetic nanoparticles in biomedicine

Bevacizumab plus Irinotecan,Fluorouracil,and Leucovorin for Metastatic Colorectal Cancer

Expert Panel on Radiation Oncology–Gynecology: Larissa J. Lee, MD; Anuja Jhingran, MD; Elizabeth Kidd, MD; David K. Gaffney, MD, PhD; Higinia Rosa Cardenes, MD, PhD; Mohamed A. Elshaikh, MD; Beth Erickson, MD; Nina A. Mayr, MD; David Moore, MD; Ajmel A. Puthawala, MD; Gautam G. Rao, MD; William Small Jr, MD; Mahesh A. Varia, MD; Andrew O. Wahl, MD; Aaron H. Wolfson, MD; Catheryn M. Yashar, MD; William Yuh, MD.

https://acsearch.acr.org/docs/3082701/Narrative/

Management of vaginal cancer

Effect of Bladder Distension on Dosimetry of Organs at Risk During Intracavitary Cervical HDR Brachytherapy Using Dose-Volume and Dose-Surface Histograms

TPS634 Background: The TARGIT-US trial is a pragmatic registry trial for women with clinically localized breast cancers who will undergo breast intraoperative radiation therapy (IORT) as sole radiation therapy post-breast conserving surgery. The TARGIT-A randomized trial of IORT versus whole breast radiation that preceded this trial has published equivalent local control outcomes for these patients (Vaidya et al. Lancet 2013). The objectives of this registry trial, therefore, are to establish eligibility criteria based on previously published trials and studies in order to allow women who meet these criteria to receive IORT on an IRB-approved protocol and to systematically collect and assess acute and long-term toxicity and outcomes in a larger cohort of patients. This will increase the general knowledge regarding this particular form of accelerated partial breast irradiation and allow further assessment of risk groups. Methods: Patients age 45 or older with small ( < 3.5cm) ER+, Her2- tumors planning to ...

TARGIT-U.S.: A registry trial of targeted intraoperative radiation therapy following breast-conserving surgery.

Delineating the Relationship between Point A Prescription Dose and Pelvic Lymph Node Doses in Intracavitary High-Dose Rate (HDR) Brachytherapy Treatment of Cervical Cancer

Neoadjuvant therapy including chemotherapy alone or concurrent chemotherapy with external bream radiation is a standard treatment strategy for borderline resectable pancreatic adenocarcinoma and is also used routinely for primary operable cancers at some institutions (1). The use of intraoperative radiation therapy (IORT) has been limited largely because of the logistical issues in delivery of radiation during surgery (2). This is the first reported case of a borderline resectable pancreas cancer patient who underwent neoadjuvant chemo-radiation therapy followed by resection with the use of IORT using the mobile IntraBeam device to boost the resection bed and improve local control by dose escalation.

/pdf/intraoperative-radiation-boost-to-the-surgical-resection-bed-4v3kgvncbg.pdf

Intraoperative Radiation "Boost" to the Surgical Resection Bed following Pancreaticoduodenectomy for a Borderline Resectable Pancreatic Carcinoma: A Case Report.

William Small

Papers

Management of vaginal cancer

Effect of Bladder Distension on Dosimetry of Organs at Risk During Intracavitary Cervical HDR Brachytherapy Using Dose-Volume and Dose-Surface Histograms

TARGIT-U.S.: A registry trial of targeted intraoperative radiation therapy following breast-conserving surgery.

Delineating the Relationship between Point A Prescription Dose and Pelvic Lymph Node Doses in Intracavitary High-Dose Rate (HDR) Brachytherapy Treatment of Cervical Cancer

Intraoperative Radiation "Boost" to the Surgical Resection Bed following Pancreaticoduodenectomy for a Borderline Resectable Pancreatic Carcinoma: A Case Report.